Jonah Larkins‐Ford
Papers
2
Total Citations
309
H-Index
2
About
Jonah Larkins-Ford is a biomedical researcher whose work sits at the dynamic intersection of infectious disease, drug discovery, and high-throughput screening technologies. His research has made significant contributions to the development of whole animal model systems for identifying novel antimicrobial compounds, with a particular focus on leveraging the nematode *Caenorhabditis elegans* as a powerful in vivo platform for anti-infective drug discovery. His most cited work, "High-Throughput Screen for Novel Antimicrobials using a Whole Animal Infection Model" (2009, 210 citations), pioneered the use of *C. elegans* infected with *Enterococcus faecalis* to screen small molecules for in vivo anti-infective properties — a methodological advance that bridged the gap between cell-based assays and mammalian models. Building on this foundation, his 2014 study (99 citations) extended the platform to combat multi-drug resistant *Staphylococcus aureus*, automating the screening process to enhance scalability and throughput against one of the most pressing nosocomial pathogens globally. Together, these contributions reflect Larkins-Ford's commitment to developing innovative, biologically relevant tools to accelerate the identification of new antimicrobials — a critically important endeavor in the ongoing fight against antibiotic resistance.
Research Focus
Key Achievements
Top Papers
- 1
- 2